SEC Form 4 · accession 0001209191-15-043663
Atara Biotherapeutics, Inc. · ATRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Beth C Seidenberg
Director · 10% Owner
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 2:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | May 14, 2015 | J | 194,200 | $0.00 | D | 2,404,828 | I | See Footnote |
| Common StockF4,F2,F5 | May 14, 2015 | J | 71,822 | $0.00 | D | 71,822 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution to the members of Kleiner Perkins Caufield & Byers XV, LLC ("KPCB XV") pursuant to the terms of its operating agreement.
- F2Ending balance reflects correction of 1 share reallocation from KPCB XV to KPCB XV Founders Fund, LLC ("KPCB XV FF"). Allocations in the original Form 3 reflected 2,599,029 shares held by KPCB XV and 77,621 shares held by KPCB XV FF.
- F3The shares are directly held by KPCB XV. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XV is KPCB XV Associates, LLC ("XV Associates"). The voting and dispositive control over the shares is shared by individual managing members of XV Associates, none of whom has veto power.
- F4Pro rata distribution to the members of KPCB XV FF pursuant to the terms of its operating agreement.
- F5The shares are directly held by KPCB XV FF. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XV FF is XV Associates. The voting and dispositive control over the shares is shared by individual managing members of XV Associates, none of whom has veto power.